Modulation of adipocyte differentiation by omega-3 polyunsaturated fatty acids involves the ubiquitin-proteasome system

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 4, 2014, Pages 590-599

  Wójcik, Cezary ^a,b   Lohe, Kimberly ^b,c   Kuang, Chenzhong ^b,c   Xiao, Yan ^b,c   Jouni, Zeida ^c   Poels, Eduard ^c,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Indiana University School of Medicine Evansville   (United States)

^c Mead Johnson Nutritionals   (United States)

^d DSM NUTRITIONAL PRODUCTS   (United States)

Author keywords

3T3 L1 cells; DHA; DPA; EPA; Fatty acid synthase; Proteasome; Ubiquitin; 3 polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; POLYUBIQUITIN; PROTEASOME; SREBF1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNSATURATED FATTY ACID;

3T3 CELL LINE; ADIPOCYTE; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; UBIQUITINATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; POLYUBIQUITIN; PROTEASOME ENDOPEPTIDASE COMPLEX; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UBIQUITINATION;

EID: 84897965511     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12194     Document Type: Article

References (51)

1. Rossmeisl M, Jelenik T, Jilkova Z, et al. Prevention and reversal of obesity and glucose intolerance in mice by DHA derivatives. Obesity. 2009; 17: 1023-31.
2. Hassanali Z, Ametaj BN, Field CJ, et al. Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat. Diabetes Obes Metab. 2010; 12: 139-47.
3. Arai T, Kim HJ, Chiba H, et al. Anti-obesity effect of fish oil and fish oil-fenofibrate combination in female KK mice. J Atheroscler Thromb. 2009; 16: 674-83.
4. Micallef M, Munro I, Phang M, et al. Plasma n-3 Polyunsaturated Fatty Acids are negatively associated with obesity. Br J Nutr. 2009; 102: 1370-4.
5. Thorsdottir I, Tomasson H, Gunnarsdottir I, et al. Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes. 2007; 31: 1560-6.
6. Poudyal H, Panchal SK, Diwan V, et al. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res. 2011; 50: 372-87.
7. Bazan NG, Molina MF, Gordon WC. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr. 2011; 31: 321-51.
8. Saltiel AR. Fishing out a sensor for anti-inflammatory oils. Cell. 2010; 142: 672-4.
9. Oh DY, Talukdar S, Bae EJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010; 142: 687-98.
10. Flachs P, Rossmeisl M, Bryhn M, et al. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci. 2009; 116: 1-16.
11. Tang QQ, Lane MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem. 2012; 81: 715-36.
12. Ciechanover A. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Neuro-degen Dis. 2012; 10: 7-22.
13. Saeki Y, Tanaka K. Assembly and function of the proteasome. Methods Mol Biol. 2012; 832: 315-37.
14. Demartino GN, Gillette TG. Proteasomes: machines for all reasons. Cell. 2007; 129: 659-62.
15. Li X, Huang HY, Chen JG, et al. Lactacystin inhibits 3T3-L1 adipocyte differentiation through induction of CHOP-10 expression. Biochem Biophys Res Commun. 2006; 350: 1-6.
16. Sakamoto K, Sato Y, Sei M, et al. Proteasome activity correlates with male BMI and contributes to the differentiation of adipocyte in hADSC. Endocrine. 2010; 37: 274-9.
17. Kitamura A, Maekawa Y, Uehara H, et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest. 2011; 121: 4150-60.
18. Xu G, Sztalryd C, Lu X, et al. Post-translational regulation of adipose differentiation-related protein by the ubiquitin/proteasome pathway. J Biol Chem. 2005; 280: 42841-7.
19. Han C, Demetris AJ, Michalopoulos GK, et al. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway. Hepatology. 2003; 38: 167-77.
20. Oliva J, French SW, Li J, et al. Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis. Exp Mol Pathol. 2012; 93: 26-34.
21. Tomaru U, Takahashi S, Ishizu A, et al. Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities. Am J Pathol. 2012; 180: 963-72.
22. Awad AB, Begdache LA, Fink CS. Effect of sterols and fatty acids on growth and triglyceride accumulation in 3T3-L1 cells. J Nutr Biochem. 2000; 11: 153-8.
23. Kopecky J, Rossmeisl M, Flachs P, et al. n-3 PUFA: bioavailability and modulation of adipose tissue function. Proc Nutr Soc. 2009; 68: 361-9.
24. Lass A, Kujawa M, McConnell E, et al. Decreased ER-associated degradation of alpha-TCR induced by Grp78 depletion with the SubAB cytotoxin. Int J Biochem Cell Biol. 2008; 40: 2865-79.
25. Wojcik C, DeMartino GN. Analysis of Drosophila 26 S proteasome using RNA interference. J Biol Chem. 2002; 277: 6188-97.
26. Kim HK, Della-Fera M, Lin J, et al. Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J Nutr. 2006; 136: 2965-9.
27. Sun C, Wei ZW, Li Y. DHA regulates lipogenesis and lipolysis genes in mice adipose and liver. Mol Biol Rep. 2011; 38: 731-7.
28. Wang YC, Kuo WH, Chen CY, et al. Docosahexaenoic acid regulates serum amyloid A protein to promote lipolysis through down regulation of perilipin. J Nutr Biochem. 2010; 21: 317-24.
29. Lee MS, Kwun IS, Kim Y. Eicosapentaenoic acid increases lipolysis through up-regulation of the lipolytic gene expression and down-regulation of the adipogenic gene expression in 3T3-L1 adipocytes. Genes Nutr. 2008; 2: 327-30.
30. Tisdale MJ. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. Nutrition. 1996; 12: S31-3.
31. Lorente-Cebrian S, Bustos M, Marti A, et al. Eicosapentaenoic acid inhibits tumour necrosis factor-alpha-induced lipolysis in murine cultured adipocytes. J Nutr Biochem. 2012; 23: 218-27.
32. Al Darwich A, Perreau C, Petit MH, et al. Effect of PUFA on embryo cryoresistance, gene expression and AMPKalpha phosphorylation in IVF-derived bovine embryos. Prostaglandins Oth Lip Med. 2010; 93: 30-6.
33. Oster RT, Tishinsky JM, Yuan Z, et al. Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARgamma mRNA, in 3T3-L1 adipocytes. Appl Physiol Nutr Met. 2010; 35: 783-9.
34. Yamazaki Y, Kawano Y, Uebayasi M. Induction of adiponectin by natural and synthetic phenolamides in mouse and human preadipocytes and its enhancement by docosahexaenoic acid. Life Sci. 2008; 82: 290-300.
35. Tishinsky JM, Ma DW, Robinson LE. Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARgamma-dependent manner in human adipocytes. Obesity. 2011; 19: 262-8.
36. Perez-Matute P, Perez-Echarri N, Martinez JA, et al. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br J Nutr. 2007; 97: 389-98.
37. Tanabe Y, Matsunaga Y, Saito M, et al. Involvement of cyclooxygenase-2 in synergistic effect of cyclic stretching and eicosapentaenoic acid on adipocyte differentiation. J Pharmacol Sci. 2008; 106: 478-84.
38. Bueno AA, Oyama LM, de Oliveira C, et al. Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue. Pflugers Arch. 2008; 455: 701-9.
39. Figueras M, Olivan M, Busquets S, et al. Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status. Obesity. 2011; 19: 362-9.
40. Suzuki K, Takahashi K, Nishimaki-Mogami T, et al. Docosahexaenoic acid induces adipose differentiation-related protein through activation of retinoid x receptor in human choriocarcinoma BeWo cells. Biol Pharm Bull. 2009; 32: 1177-82.
41. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259: 87-91.
42. Ahn IS, Choi BH, Ha JH, et al. Isomer-specific effect of conjugated linoleic acid on inflammatory adipokines associated with fat accumulation in 3T3-L1 adipocytes. J Med Food. 2006; 9: 307-12.
43. Oliver E, McGillicuddy FC, Harford KA, et al. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. J Nutr Biochem. 2012; 23: 1192-200.
44. Whitehouse AS, Tisdale MJ. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation. Biochem Biophys Res Comm. 2001; 285: 598-602.
45. Yang YC, Lii CK, Wei YL, et al. Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-kappaB pathways. J Nutr Biochem. 2012; 4: 204-12.
46. Lu IF, Hasio AC, Hu MC, et al. Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor alpha and inhibits the downstream signaling target in MCF-7 breast cancer cells. J Nutr Biochem. 2010; 21: 512-7.
47. Calviello G, Resci F, Serini S, et al. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. Carcinogenesis. 2007; 28: 1202-9.
48. Mikhail AT, Babcock TA, Jho DH, et al. Modulation of the ubiquitin-proteasome proteolytic pathway by eicosapentaenoic acid supplementation in a model of progressive malignancy. J Parent Ent Nutr. 2003; 27: 105-9.
49. Ogasawara J, Kitadate K, Nishioka H, et al. Oligonol-induced degradation of perilipin 1 is regulated through lysosomal degradation machinery. Nat Prod Commun. 2012; 7: 1193-6.
50. Wojcik C. Regulation of apoptosis by the ubiquitin and proteasome pathway. J Cell Mol Med. 2002; 6: 25-48.
51. Basseri S, Lhotak S, Sharma AM, et al. The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J Lip Res. 2009; 50: 2486-501.